GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile

Date: February 13, 2018
Pages: 129
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GC1F10E4AE5EN
Leaflet:

Download PDF Leaflet

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
Summary

GlaxoSmithKline Plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cancer, cardiovascular, HIV and infectious diseases, respiratory, immuno-inflammation and rare diseases. The company offers over-the-counter (OTC) products for pain relief, oral health, nutrition, skin health and respiratory diseases. GSK’s vaccine portfolio cover various diseases including hepatitis, diphtheria, tetanus, whooping cough, rotavirus and HPV infections, measles and bacterial meningitis, among others. The company sells its products through wholesalers, pharmacies, hospitals, physicians and other groups. GSK is headquartered in Brentford, Middlesex, the UK.

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deal Details
Venture Financing
NeuSpera Medical Raises USD26 Million in Series B Financing Round
SetPoint Medical Raises USD30 Million in Series D Financing
Saluda Medical Raises USD39.4 Million in Series D Financing
Progyny Raises Additional USD10 Million in Series B Financing
SetPoint Medical Raises Funds through Venture Financing
Propeller Health Raises USD21.5 Million in Series C Financing
CVRx Raises USD57.7 Million in Series G Financing
Cala Health Raises USD18 Million in Series A Financing Round
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing
Avhana Health Raises USD0.7 Million in Seed Financing
Progyny Raises Additional Funds through Venture Financing
ZappRx Raises USD5.6 Million in Series A Financing
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing
ZappRx Raises US$2 Million In Seed Financing
Setpoint Medical Raises US$27 Million In Venture Financing
Health XL Raises Funds Through Venture Financing
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing
SR One Plans To Invest In Biotechnology Company
IlluminOss Medical Raises US$28 Million In Series C Financing
Auxogyn Raises US$18 Million In Series B Financing
Partnerships
NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare
Owlstone Medical Enters into Co-Development Agreement with GlaxoSmithKline
GlaxoSmithKline to Form Joint Venture with Verily Life Sciences
GlaxoSmithKline May Form Joint Venture with Qualcomm
Propeller Health Expands Agreement with GlaxoSmithKline
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK
Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare
Ionis Pharmaceuticals Enters Into Licensing Agreement with Glaxo Group and GlaxoSmithKline
Equity Offering
Response Genetics Completes Private Placement Of Shares For US$9 Million
Debt Offering
GlaxoSmithKline Raises USD832.8 Million in Public Offering of Bonds Due 2026
GlaxoSmithKline Raises USD1,428 Million in Public Offering of Bonds Due 2020
Asset Transactions
Sinclair IS Pharma Acquires Atlean From Stiefel Labs
Acquisition
GlaxoSmithKline May Acquire Vectura for USD1.62 Billion
United Therapeutics May Sell Itself
GlaxoSmithKline May Acquire Remaining 36.5% Stake in GlaxoSmithKline Consumer Healthcare from Novartis for USD10.3 Billion
Teleflex Acquires Semprus BioSciences For Up To US$80 Million
GlaxoSmithKline Plc - Key Competitors
GlaxoSmithKline Plc - Key Employees
GlaxoSmithKline Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Strategy And Business Planning
Oct 30, 2017: GSK opens new regional headquarters for Asia in Singapore
Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
Financial Announcements
Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in 2017
Oct 25, 2017: GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER
Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
Apr 26, 2017: GSK delivers another quarter of continued progress
Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
Corporate Communications
Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice
Nov 08, 2017: Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser
Nov 08, 2017: Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK
Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
Jul 21, 2017: GSK announces Board and Committee changes
Jun 19, 2017: GSK confirms start date for Luke Miels
Apr 04, 2017: GSK responds to Cyclone Debbie
Jan 20, 2017: Luke Miels will succeed Abbas Hussain as President, Global Pharmaceuticals, GSK
Jan 19, 2017: Abbas Hussain to leave GSK
Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
Other Significant Developments
Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment Deals By Type, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deal Details
Venture Financing
NeuSpera Medical Raises USD26 Million in Series B Financing Round
SetPoint Medical Raises USD30 Million in Series D Financing
Saluda Medical Raises USD39.4 Million in Series D Financing
Progyny Raises Additional USD10 Million in Series B Financing
SetPoint Medical Raises Funds through Venture Financing
Propeller Health Raises USD21.5 Million in Series C Financing
CVRx Raises USD57.7 Million in Series G Financing
Cala Health Raises USD18 Million in Series A Financing Round
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing
Avhana Health Raises USD0.7 Million in Seed Financing
Progyny Raises Additional Funds through Venture Financing
ZappRx Raises USD5.6 Million in Series A Financing
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing
ZappRx Raises US$2 Million In Seed Financing
Setpoint Medical Raises US$27 Million In Venture Financing
Health XL Raises Funds Through Venture Financing
HTG Molecular Diagnostics Raises US$7.5 Million In Series E Financing
SR One Plans To Invest In Biotechnology Company
IlluminOss Medical Raises US$28 Million In Series C Financing
Auxogyn Raises US$18 Million In Series B Financing
Partnerships
NeuroMetrix to Enter into Agreement with GlaxoSmithkline Consumer Healthcare
Owlstone Medical Enters into Co-Development Agreement with GlaxoSmithKline
GlaxoSmithKline to Form Joint Venture with Verily Life Sciences
GlaxoSmithKline May Form Joint Venture with Qualcomm
Propeller Health Expands Agreement with GlaxoSmithKline
Thermo Fisher Scientific Enters into Co-Development Agreement with GlaxoSmithKline and Pfizer
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK
Feinstein Institute For Medical Research Enters Into Research Agreement With GSK, University of Pennsylvania And MIT
AB-Biotics Enters Into Co-Promotion Agreement With GlaxoSmithKline For Neurofarmagen
KineMed Enters Into Co-Development Agreement With GlaxoSmithKline
Epistem Holdings Enters Into Co-Development Agreement With GlaxoSmithKline
Siemens Healthcare Diagnostics Enters Into Co-Development Agreement With ViiV Healthcare
Ionis Pharmaceuticals Enters Into Licensing Agreement with Glaxo Group and GlaxoSmithKline
Equity Offering
Response Genetics Completes Private Placement Of Shares For US$9 Million
Debt Offering
GlaxoSmithKline Raises USD832.8 Million in Public Offering of Bonds Due 2026
GlaxoSmithKline Raises USD1,428 Million in Public Offering of Bonds Due 2020
Asset Transactions
Sinclair IS Pharma Acquires Atlean From Stiefel Labs
Acquisition
GlaxoSmithKline May Acquire Vectura for USD1.62 Billion
United Therapeutics May Sell Itself
GlaxoSmithKline May Acquire Remaining 36.5% Stake in GlaxoSmithKline Consumer Healthcare from Novartis for USD10.3 Billion
Teleflex Acquires Semprus BioSciences For Up To US$80 Million
GlaxoSmithKline Plc - Key Competitors
GlaxoSmithKline Plc - Key Employees
GlaxoSmithKline Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Recent Developments
Strategy And Business Planning
Oct 30, 2017: GSK opens new regional headquarters for Asia in Singapore
Feb 16, 2017: GSK and EMBL have signed an agreement to enhance understanding of disease and drug mechanisms
Financial Announcements
Feb 07, 2018: GSK delivers improvements in sales, margins and cash flow in 2017
Oct 25, 2017: GSK delivers Q3 sales of £7.8 billion, +4% AER, +2% CER
Jul 26, 2017: GSK delivers further progress in Q2 and sets out new priorities for the Group
Apr 26, 2017: GSK delivers another quarter of continued progress
Feb 08, 2017: GlaxoSmithKline: Results announcement for the fourth quarter 2016
Corporate Communications
Jan 09, 2018: Representative Director and President of GlaxoSmithKline Corporation Personnel notice
Nov 08, 2017: Patrick Vallance, President, R&D, GSK to become UK Government's Chief Scientific Adviser
Nov 08, 2017: Dr Hal Barron appointed Chief Scientific Officer and President, Research & Development, GSK
Jul 25, 2017: Karenann Terrell appointed Chief Digital & Technology Officer, GSK
Jul 21, 2017: GSK announces Board and Committee changes
Jun 19, 2017: GSK confirms start date for Luke Miels
Apr 04, 2017: GSK responds to Cyclone Debbie
Jan 20, 2017: Luke Miels will succeed Abbas Hussain as President, Global Pharmaceuticals, GSK
Jan 19, 2017: Abbas Hussain to leave GSK
Jan 19, 2017: Luke Miels appointed President, Global Pharmaceuticals, GSK
Other Significant Developments
Aug 30, 2017: GSK responds to UK Life Sciences Industrial Strategy
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF FIGURES

GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018
GlaxoSmithKline Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: